Hosted by Unknown Host · 🇺🇸 US · EN · 32 episodes
Established thought leaders with verified media credentials.
This podcast features content for the modern ophthalmologists, including topics such as cataract and refractive surgery, glaucoma, and retinal disease, among others. Evolve’s podcasts help today's ophthalmologists stay current on important topics in an easy-to-access, on-demand format.
Unknown Host hosts Let’s Talk Ophthalmology: an Evolve Medical Education Podcast, a education show with 32 episodes published.
The pipeline for the treatment of wet age-related macular degeneration includes therapies that focus on new molecular targets. Carl J. Danzig, MD, FASRS, discusses a tyrosine kinase inhibitor. This activity is supported
Show notesDavid Eichenbaum, MD, will discuss the bioresorbable, hydrogel axitinib intravitreal implant that is under investigation in the SOL-1 phase 3 trial for the treatment of neovascular age-related macular degeneration. This
Show notesMargaret A. Chang, MD, MS, will discuss gene therapies in the pipeline for the treatment of neovascular age-related macular degeneration. This activity is supported by an independent medical education grant from Ocular T
Show notesDrs. Dilsher Dhoot and Arshad M. Khanani explain the key aspects of the recently released FDA guidelines for clinical trial design in neovascular age-related macular degeneration and how these changes will influence the
Show notesKendall E. Donaldson, MD, MS and Christopher E. Starr, MD, highlight best practices when treating neurotrophic keratitis, including differential diagnosis, corneal sensitivity testing, the new classification system, trea
Show notesDrs. Donaldson and Starr delve into cenegermin’s clinical trial data and whether or not it should be used in patients with stage 1 neurotrophic keratitis (NK). They also discuss a handful of investigational agents for tr
Show notesKendall E. Donaldson, MD, MS and Christopher E. Starr, MD, discuss why it’s important to treat stage 1 neurotrophic keratitis, the treatment options for each stage, and a patient who was treated with multiple therapies.
Show notesIn this case-based discussion focused on diabetic macular edema, Murtaza Adam, MD, FASRS, and Lejla Vajzovic, MD, FASRS, highlight the use of more durable treatment options and how to incorporate these second-generation
Show notesMurtaza Adam, MD, FASRS, and Lejla Vajzovic, MD, FASRS, discuss two cases involving patients with neovascular age-related macular degeneration and the decision-making process used to determine the best treatment approach
Show notesBack by popular demand, this fun and exciting game show-style program features key opinion leaders (KOLs) as contestants! Hosted by Dr. Blake K. Williamson, this episode is full of learning and laughter! The winner of Ro
Show notesThis popular program is a fun and exciting game show-style quiz competition that features key opinion leaders (KOLs) as contestants. Hosted by Program Chair Blake K. Williamson, MD, MPH, MS, the second of three rounds fe
Show notesThis popular program is a fun and exciting game show-style quiz competition that features key opinion leaders (KOLs) as contestants. Hosted by Program Chair Blake K. Williamson, MD, MPH, MS, the first of three rounds fea
Show notesIn this insightful microlearning podcast, Dr. Kim Cockerham explores the impact of TED on patients' quality of life, outlines essential questions for diagnosis, and describes a compelling case of inflammatory TED that re
Show notesJoin Amina Malik, MD, as she describes the common signs and symptoms of TED and offers valuable insights into successfully treating and comanaging a case of moderate-to-severe TED. This activity is supported by an unrest
Show notesIn this informative episode, Dr. Amina Malik navigates the different classification systems for TED severity and inflammatory activity, explores the treatment options for varying severity of disease, and concludes with a
Show notesKim Cockerham, MD, FACS, explains the challenges of diagnosing TED and recounts a case of advanced TED, which involved a patient who had previously been misdiagnosed with dry eye and ocular hypertension/glaucoma by six o
Show notesIn this episode, Carl J. Danzig, MD and John W. Kitchens, MD, discuss two case studies, one involving a 15-year-old who presents with neovascularization and an elderly patient with an extensive history of treatment who w
Show notesCarl J. Danzig, MD and John W. Kitchens, MD, discuss two case studies, including a treatment-naïve patient with proliferative diabetic retinopathy and diabetic macular edema and a patient with a long history of anti-VEGF
Show notesDavid Chin Yee, MD, FASRS and Esther Lee Kim, MD, discuss second-generation retinal disease therapies and how they may offer benefits for certain patients. These retina specialists also share their experience with the ne
Show notesDavid Chin Yee, MD, FASRS and Esther Lee Kim, MD, discuss clinical trial data of newer, longer duration retinal disease therapies and share real-world case studies utilizing these new agents for their patients. This acti
Show notesSponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Let’s Talk Ophthalmology: an Evolve Medical Education Podcast has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their education audience.
Let’s Talk Ophthalmology: an Evolve Medical Education Podcast is hosted by Unknown Host. The show is categorised under education (science) and has published 32 episodes.
Let’s Talk Ophthalmology: an Evolve Medical Education Podcast has published 32 episodes.
Let’s Talk Ophthalmology: an Evolve Medical Education Podcast regularly covers education, science, life. It sits in the education category, with a science focus.
Let’s Talk Ophthalmology: an Evolve Medical Education Podcast is accessible for guests with genuine education expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Let’s Talk Ophthalmology: an Evolve Medical Education Podcast hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Let’s Talk Ophthalmology: an Evolve Medical Education Podcast average 28 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Let’s Talk Ophthalmology: an Evolve Medical Education Podcast's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 13 days ago.
